POZEN About UsProduct CandidatesInvestorNewsCorporate GovernanceBusiness Development

POZEN to Host Investor and Analyst Event on December 8, 2009
POZEN Announces Start of Enrollment For PA32540 Phase 3 Program
POZEN Inc. at The Credit Suisse Phoenix Healthcare Conference
November 13, 2009 at 8:30 AM PT
02/08/10 4:00 p.m. ET
NASDAQ: Pozen $5.58
  
Change:  - 0.26 4.45%
Volume: 40,727
Search